Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in
Par un écrivain mystérieux
Description
Longer-term effectiveness of a heterologous coronavirus disease 2019 (COVID-19) vaccine booster in healthcare workers in Brazil, Antimicrobial Stewardship & Healthcare Epidemiology
Vaccines, Free Full-Text
Measuring vaccine effectiveness from limited public health datasets: Framework and estimates from India's second COVID wave
Frontiers Immunogenicity, Effectiveness, and Safety of Inactivated Virus ( CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 Study
Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2
Efficacy of COVID-19 Vaccines against the Omicron Variant of SARS-CoV-2: A Review
depuis
par adulte (le prix varie selon la taille du groupe)
